Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
Cash from Operating Activities
Gujarat Themis Biosyn Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gujarat Themis Biosyn Ltd
BSE:506879
|
Cash from Operating Activities
₹574.9m
|
CAGR 3-Years
81%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Operating Activities
₹72.1B
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Operating Activities
₹37.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Operating Activities
₹121.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash from Operating Activities
₹37.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Cash from Operating Activities
₹18.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gujarat Themis Biosyn Ltd's Cash from Operating Activities?
Cash from Operating Activities
574.9m
INR
Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Cash from Operating Activities amounts to 574.9m INR.
What is Gujarat Themis Biosyn Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
81%
Over the last year, the Cash from Operating Activities growth was 90%. The average annual Cash from Operating Activities growth rates for Gujarat Themis Biosyn Ltd have been 81% over the past three years .